Biogen Inc logo

BIIB - Biogen Inc News Story

$269.17 -2.4  -0.9%

Last Trade - 2:35pm

Sector
Healthcare
Size
Large Cap
Market Cap £29.41bn
Enterprise Value £32.80bn
Revenue £9.07bn
Position in Universe 314th / 6849

BRIEF-New Data At AAN 2021 From Across Biogen's MS Portfolio Demonstrate Positive Impact Of Treatment On People Living With Relapsing Multiple Sclerosis

Fri 16th April, 2021 12:32pm
April 16 (Reuters) - Biogen Inc  BIIB.O :
    * NEW DATA AT AAN 2021 FROM ACROSS BIOGEN’S MS PORTFOLIO
DEMONSTRATE POSITIVE IMPACT OF TREATMENT ON PEOPLE LIVING WITH
RELAPSING MULTIPLE SCLEROSIS
    * BIOGEN INC - NEW FINDINGS FROM MS PATHS SHOW THAT
TREATMENT WITH
TYSABRI  CAN LEAD TO MEANINGFUL IMPROVEMENTS IN MENTAL & SOCIAL
HEALTH COMPARED TO OCREVUS
    * BIOGEN INC - REAL-WORLD DATA FROM VUMERITY(DIROXIMEL
FUMARATE)
REINFORCE TREATMENT'S POSITIVE GASTROINTESTINAL TOLERABILITY
PROFILE

Source text for Eikon:  ID:nGNX68WPGY 
Further company coverage:  BIIB.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.